Brain atrophy patterns in multiple sclerosis patients treated with natalizumab and its clinical correlates

BACKGROUND: Multiple sclerosis (MS) is defined as a demyelinating disorder of the central nervous system, witnessing over the past years a remarkable progress in the therapeutic approaches of the inflammatory process. Yet, the ongoing neurodegenerative process is still ambiguous, under‐assessed, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Rekik, Arwa, Aissi, Mona, Rekik, Islem, Mhiri, Mariem, Frih, Mahbouba Ayed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120898/
https://www.ncbi.nlm.nih.gov/pubmed/35398999
http://dx.doi.org/10.1002/brb3.2573

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120898/
https://www.ncbi.nlm.nih.gov/pubmed/35398999
http://dx.doi.org/10.1002/brb3.2573

Ejemplares similares